BR-cadherin Inhibitors

BR-cadherin, officially recognized as cadherin 12 (CDH12) within the expansive cadherin superfamily, embodies a critical cell adhesion molecule that plays pivotal roles in the regulation of cellular processes, including proliferation, differentiation, and migration. This protein, encoded by the CDH12 gene in humans, is predominantly expressed in the brain, where it significantly contributes to the formation and maintenance of the nervous system's structural and functional integrity. The cadherin superfamily, to which BR-cadherin belongs, is characterized by calcium-dependent adhesion molecules that facilitate cell-cell adhesion, a fundamental mechanism ensuring the cohesiveness of multicellular organisms. BR-cadherin's role extends to influencing neurodevelopmental pathways and processes, thereby underscoring its importance in neural patterning and connectivity. Its unique structure, featuring extracellular cadherin repeats and a highly conserved cytoplasmic tail, enables it to mediate homophilic cell-cell interactions, which are essential for the precise assembly and function of neuronal circuits.

The inhibition of BR-cadherin's function encompasses a range of mechanisms that disrupt its cell adhesion properties and downstream signaling pathways, ultimately affecting tissue architecture and cellular behavior. Inhibition can occur through various biological mechanisms, including the alteration of its expression levels, post-translational modifications that affect its stability or cell surface localization, and competitive binding by other molecules that interfere with its ability to mediate cell-cell adhesion. Additionally, the disruption of calcium ions' availability, crucial for the structural integrity and adhesive function of cadherins, represents another inhibitory strategy. Intracellularly, the modulation of the cytoplasmic domain of BR-cadherin, which interacts with catenins to link the cadherin complex to the actin cytoskeleton, can impair its signaling capabilities and influence cellular processes such as migration and morphogenesis. Furthermore, the enzymatic cleavage of BR-cadherin by specific proteases can lead to a functional loss of adhesion, contributing to the dynamic regulation of cellular adhesions in response to developmental and environmental cues. Collectively, these inhibitory mechanisms highlight the complex regulation of BR-cadherin and its central role in maintaining cellular and tissue homeostasis.